That the product has passed specified efficacy tests against a defined range of organisms at a stated concentration and contact time - and the tests differ by jurisdiction.

The phrase is a marketing summary of regulatory status. In each market a scheme defines which tests a product must pass to make particular claims, and the label should cite the standards it has met.

What it does not mean is a particular chemistry, a particular strength, or suitability for every healthcare task. A product may be hospital-grade and still be unsuitable for the specific organism or surface in front of you.

The useful questions are: which organisms, at what contact time, under clean or dirty conditions, and on which surfaces.

Where a healthcare protocol specifies disinfection, it should cite the standard required rather than the marketing term, because the term is not portable between markets.

Bacterial spores are the hardest, then mycobacteria, then non-enveloped viruses; enveloped viruses and most vegetative bacteria are comparatively easy.

The generally accepted order of resistance runs from prions - outside the scope of ordinary disinfection - through spores, mycobacteria, non-enveloped viruses, fungi, vegetative bacteria and finally enveloped viruses, which are the most susceptible.

The practical implication is that a product effective against an enveloped virus tells you almost nothing about its performance against a spore-forming organism.

Spore-forming bacteria associated with healthcare outbreaks require a sporicidal product, generally chlorine-based or a peracid, used at the specified concentration and contact time.

Non-enveloped viruses that cause outbreaks of gastrointestinal illness are notably resistant and require products specifically tested against them.

Match the product to the organism of concern rather than to a general claim.

Organic material consumes the active and physically shields organisms, which is why efficacy tests are conducted under both clean and dirty conditions.

Blood, body fluids, food residue and general soil all react with disinfectant actives. Chlorine in particular is consumed rapidly by organic matter, so a solution applied to a soiled surface may be substantially spent before the contact time elapses.

Soil also forms a physical barrier. Organisms within a dried film or under a layer of residue are not reached by the solution at all.

Test standards reflect this by specifying an interfering substance, and results are reported for clean and dirty conditions separately. A product that only passes under clean conditions requires a thorough clean first.

In practice this means cleaning and disinfection are one process. Two-step protocols, or a validated combined cleaner-disinfectant used with adequate mechanical action, are the ways it is achieved.

In the breadth of tested claims, the evidence behind them, and usually in material compatibility and residue - not necessarily in raw strength.

A general-purpose disinfectant typically carries claims against a limited set of common organisms under clean conditions. That is adequate for offices, retail and much commercial cleaning.

Healthcare products carry a broader and more specific set of claims, tested against organisms relevant to healthcare-associated infection, often including harder targets and dirty-condition testing.

They are also selected for compatibility with medical devices and surfaces, and for residue characteristics acceptable in patient areas - a sticky residue that attracts soil is unacceptable on a bed rail.

Cost per litre is higher, which is why the correct approach is to match the product to the risk of the area rather than standardising everywhere on the strongest option.

Short enough that the surface stays wet for the whole period - which in practice means products with contact times of a few minutes or less for routine work.

A product requiring ten minutes of visible wetness is unusable for routine surface cleaning, because no ordinary application keeps a surface wet that long in a warm, ventilated room.

For that reason, routine disinfection specifies products with short contact times, while longer times are reserved for terminal cleaning, outbreak response and situations where reapplication is built into the procedure.

Where a long contact time is genuinely required, the technique changes: heavier application, covering with a cloth, or repeated application through the period.

Claims are only valid at the stated time. A product used for one minute when its claim requires five has no established efficacy at all, whatever the label says on the front.

For routine work on lightly soiled surfaces, yes - and they materially improve compliance because they remove a step people skip.

A two-step process requires staff to clean, then disinfect with the correct contact time. In practice the second step is frequently abbreviated or missed, so a well-formulated one-step product used correctly can outperform a theoretically superior protocol executed badly.

One-step products are formulated so the detergent component does not neutralise the disinfectant, which is not true of simply mixing a cleaner and a disinfectant.

They are not adequate for heavily soiled surfaces, spills of body fluids, or outbreak conditions, where a dedicated clean followed by a specified disinfectant is required.

Mechanical action still matters. Wiping with pressure and a systematic pattern is part of what removes organisms, and no chemistry substitutes for it.

No - authorisation is national or regional, and a claim valid in one market may not be permitted in another.

Disinfectants are regulated products in most jurisdictions, with schemes governing which actives may be used, what claims may be made and what testing supports them. Registration is not mutually recognised across markets.

The consequence for a buyer is that the label from one country may not reflect what is permitted locally, and imported product may not be lawfully usable in a regulated setting.

In healthcare and food production this matters directly, because auditors check that chemicals in use are authorised for the setting and the jurisdiction.

The practical step is to confirm the product's local authorisation status and its cited standards before adopting it site-wide, and to keep that documentation with the safety data sheets.